Agilon Health, Inc. Hits New 52-Week High of $100.72

Agilon Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 100.72 on June 8, 2026. This achievement marks a remarkable performance for the small-cap company, which operates within the Pharmaceuticals & Biotechnology industry. Over the past year, Agilon Health has demonstrated an impressive growth trajectory, with a staggering 1,322.84% increase in its stock price, significantly outperforming the S&P 500, which has risen by 23.42% during the same period. With a market capitalization of USD 164 million, Agilon Health continues to navigate the competitive landscape of its industry. Despite being a loss-making entity, the company maintains a price-to-book ratio of 1.30. The stock's journey from a 52-week low of USD 0.30 to its current high underscores the volatility and potential within the market. Investors and market observers will be keen to monitor how Agilon Health capitalizes on this momentum moving forward.